| 产品描述: | PF-04885614 is a potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has potential for neurological and neurodevelopmental diseases treatment |
| 靶点: |
Sodium Channel;SodiumChannel |
| 参考文献: |
1. Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.506 ml |
17.528 ml |
35.056 ml |
| 5 mM |
0.701 ml |
3.506 ml |
7.011 ml |
| 10 mM |
0.351 ml |
1.753 ml |
3.506 ml |
| 50 mM |
0.07 ml |
0.351 ml |
0.701 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |